Keating Financial Advisory Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.2K Buy
117
+50
+75% +$18.5K 0.01% 703
2026
Q1
$19.6K Sell
67
-45
-40% -$14.8K ﹤0.01% 906
2025
Q4
$39.3K Buy
+112
New +$37.8K 0.01% 713

Other funds holding ELV

Keating Financial Advisory Services's ELV Position: Q2 2026 in Review

Keating Financial Advisory Services increased its Elevance Health (ELV) stake by 75% in Q2 2026, buying an estimated $18.5K and bringing the position to 117 shares worth $45.2K. The position accounts for 0.01% of the portfolio, ranked #703.

Keating Financial Advisory Services first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Keating Financial Advisory Services held 117 shares of Elevance Health worth $45.2K as of Q2 2026.
  • Keating Financial Advisory Services bought 50 Elevance Health shares in Q2 2026, an estimated $18.5K.
  • Elevance Health made up 0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #703 holding.
  • Keating Financial Advisory Services first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.